Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Fertility Preservation Coverage in the States Aaron Segel Associate Director, State Advocacy ASCO ASCO Priority Issue: Fertility Preservation • ASCO’s Clinical Practice Guideline “Fertility Preservation in Patients with Cancer” recommends providers discuss fertility with patients before starting treatment • 2020 JAMA study shows discussing fertility options before treatment …
Advances in Immunotherapy – What the Future May Hold Hawaii Society of Clinical Oncology 2023 Annual Conference October 21st, 2023 Siddharth Sheth Assistant Professor of Medicine Division of Oncology Department of Medicine University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Disclosures • Sheth: no relevant disclosures to this talk …
In 2020, this community-based cancer program started laying the foundation for a disease-site specific oncology patient navigation program that would grow exponentially over the next 2 years.
WVOS 10.26 Attendee Roster Updated 10.25.xlsx WVOS 2023 Fall Conference October 26th, 2023 WVU Erickson Alumni Center Morgantown, WV Attendee Roster First Name Last Name Title Account Name Amy Bankston Account Executive AbbVie Inc. Sara Orndoff Snyder Account Executive AbbVie Inc. Gina Quinlan Oncology Nurse Educator AbbVie Inc. David Walkup Account Executive AbbVie Inc. …
This complimentary dinner will focus on the purpose and opportunities involved in influencing state and national guidelines for medical necessity in oncology. Learn about the proposed and final rules regarding oncology and how practicing physicians can modify existing rules. Bottom line enhancements with financial analytics, authorizations and financial clearance for patients …
ASSOCIATION OF COMMUNITY CANCER CENTERS 1 Background Myeloproliferative neoplasms, while rare, are a group of hematopoietic stem cell cancers that despite recent advancements in the realm of hematologic malignan- cies, continue to be a challenge for patients diagnosed with these cancers. Gene expression analysis and next-generation sequencing has led to the identifi- cation of unique …
Agenda for the 2023 Shreveport, Louisiana Oncology Reimbursement Meeting 8:00 – 9:00 AM Breakfast 9:00 – 9:45 AM How to Build a Robust Financial Advocacy Program Rudy Garcia III, MPH, Business Administration Supervisor Dell Children’s Blood and Cancer Center of Central Texas Ascension The ACCC Financial Advocacy Network and its members have spent much of its time over the …
Agenda for the 2023 Seattle, Washington Oncology Reimbursement Meeting 8:00 – 9:00 AM Breakfast 9:00 – 9:45 AM What’s Going on in DC and My State: Why It Matters Kathy Oubre, MS, Chief Executive Officer Pontchartrain Cancer Center - Covington Before change is made via federal legislation, often efforts begin in grassroots and at the state level. Understand how you can …
CANCER BUZZ spoke to Melissa Frey, MD, MS, and Leigha Senter, MS, CGC to discuss germline and somatic testing for patients with ovarian cancer.
ACCC 50TH ANNUAL MEETING & CANCER CENTER BUSINESS SUMMIT TRENDS in Business, Technology & Policy Sponsorship Prospectus For more information, contact: ACCC Corporate Development Sabina Gargiulo, sgargiulo@accc-cancer.org www.accc-cancer.org/AMCCBS February 28–March 1, 2024 | Capital Hilton | Washington, DC 2 ACCC 50th Annual Meeting & Cancer Center Business …
For more information, contact Sabina Gargiulo, sgargiulo@accc-cancer.org 7 ACCC ANNUAL MEETING AND CANCER CENTER BUSINESS SUMMIT February 28–March 1, 2024 | Capital Hilton | Washington, DC SPONSORSHIP AGREEMENT Company Name _____________________________________________________________ Website________________________________________________ (as it should appear in print) …
ACCC ANNUAL MEETING AND CANCER CENTER BUSINESS SUMMIT (AMCCBS) 1 Sponsorship & Exhibit Rules & Regulations Eligibility for Sponsoring & Exhibiting The Annual Meeting and Cancer Center Business Summit (AMCCBS) is an ACCC premiere event. Its purpose is to enhance the professional development of its members. Accordingly, ACCC reserves the exclusive and total right to control …
SCOS ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
TACOS ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
NCOA ONCOLOGY DRUG NEWSLETTER O C T O B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Motixafortide (Aphexda) The FDA has granted approval to motixafortide (Aphexda) used in combination with filgrastim granulocyte-colony stimulating factor …
Disclosures and Conflict of Interest (COI) Mitigation Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: Michael Carney, MD; Christian Downs; Aaron Segal; Emmanuel Zibakalam; Nadine Barrett, PhD; Stephanie Si, MD; and the staffs of the Hawaii Society of Clinical Oncology and Physicians’ Education …
Comprehensive cancer care encompasses a broad range of services that are commonly referred to as supportive oncology care. These services—which encompass the care continuum from patient navigation and fertility preservation to spiritual support and palliative care—are not just "nice to have" additions.